Kevin is the CEO of Biorez, an early-stage medical device company, developing bio-inductive implants for the $7B sports medicine market that help restore joint stability and aid in the direct healing and regeneration of new functional tissue. He is an experienced entrepreneur and expert in the field of tissue engineering, having raised $12M in various fundings for Biorez and co-authored 19 peer-reviewed publications with 400+ citations. Previously, he was the first full-time engineer at STR during the first clinical investigation of a synthetic bio-inductive scaffold for ACL reconstruction and was a part of the first clinical investigation of a bio-inductive scaffold as a vascular graft while a graduate student at Yale University.
Kevin is the CEO of Biorez, an early-stage medical device company, developing bio-inductive implants for the $7B sports medicine market that help restore joint stability and aid in the direct healing and regeneration of new functional tissue. He is an experienced entrepreneur and expert in the field of tissue engineering, having raised $12M in various fundings for Biorez and co-authored 19 peer-reviewed publications with 400+ citations. Previously, he was the first full-time engineer at STR during the first clinical investigation of a synthetic bio-inductive scaffold for ACL reconstruction and was a part of the first clinical investigation of a bio-inductive scaffold as a vascular graft while a graduate student at Yale University.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy